Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07081087 · ClinicalTrials.gov registry record
Development of a Peripheral Blood Assay to Replace BM Evaluation in Cytopenia - a Multi-Center Observational Study
A clinical trial of Cytopenia, sponsored by Weizmann Institute of Science.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 2
- Study locations
NCT07081087 is a study of Cytopenia that is actively recruiting participants, run by Weizmann Institute of Science. The registered enrollment target is 1,500 participants, above the 243-participant average among 11 other Cytopenia trials with a reported enrollment target (517% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT07081087, a study of Cytopenia, is actively recruiting participants, sponsored by Weizmann Institute of Science.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to validate a novel, non-invasive diagnostic approach for blood and bone marrow malignancies using single-cell RNA sequencing of circulating hematopoietic stem and progenitor cells (cHSPCs) from peripheral blood. Building on prior work defining normal cHSPC profiles in healthy individuals, the study introduces a pipeline for identifying blood pathologies, with a focus on improving the diagnosis and subclassification of myelodysplastic syndromes (MDS). A multi-center clinical trial is proposed to evaluate the method's ability to predict bone marrow results in patients with cytopenia, potentially reducing reliance on bone marrow biopsies.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST PERIBLOOD
Study Locations (2)
California
- University of California San Diego - San Diego
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07081087
The ClinicalTrials.gov registry entry for NCT07081087 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 243-participant average among 11 other Cytopenia trials with a reported enrollment target (517% higher). The listed sponsor is Weizmann Institute of Science, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cytopenia appearing as the primary indexed condition, and to 1 intervention - of which PERIBLOOD is the first listed.
NCT07081087 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Florida.
Frequently Asked Questions
What is clinical trial NCT07081087 about?
NCT07081087 is a clinical study titled "Development of a Peripheral Blood Assay to Replace BM Evaluation in Cytopenia - a Multi-Center Observational Study". This study aims to validate a novel, non-invasive diagnostic approach for blood and bone marrow malignancies using single-cell RNA sequencing of circulating hematopoietic stem and progenitor cells (cHSPCs) from peripheral blood. Building on prior work defining normal cHSPC profiles in healthy indivi...
What is the current status of trial NCT07081087?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2025-06-01. Estimated completion is 2028-12.
What conditions does trial NCT07081087 study?
This clinical trial studies the following conditions: Cytopenia.
What interventions are being tested in trial NCT07081087?
The interventions under investigation include: PERIBLOOD (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07081087?
This trial is sponsored by Weizmann Institute of Science, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07081087 being conducted?
This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cytopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
RECRUITING · NA
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
-
Early Intervention in High Risk CCUS
RECRUITING · Early Phase 1
-
Danazol for Treatment of Cytopenias in Patients With Cirrhosis
RECRUITING · Phase 2
-
A Study of Emapalumab for Pediatric Aplastic Anemia
RECRUITING · Phase 2
-
A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.